>
Organization
Aileron Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Aileron Therapeutics, Inc.

... relapsed/refractory AML continues WATERTOWN, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stabilized, cell-permeating peptides ...
... Aileron Therapeutics has entered a clinical trial collaboration with Pfizer to evaluate the ...
... WATERTOWN, Mass., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stabilized, cell-permeating peptides ...
... President of Research WATERTOWN, Mass., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), the clinical stage leader in the field of stabilized, cell-permeating peptides ...
... Investigator-Initiated Phase 1Trial of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer WATERTOWN, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Aileron ...
... WATERTOWN, Mass., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical stage leader in the field of stabilized, cell-permeable ...
... Cancer Therapeutics Symposium CAMBRIDGE, Mass., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), the clinical stage leader in the discovery and development of ...
... WATERTOWN, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stapled peptide therapeutics ...
Subscribe now for full coverage on Aileron Therapeutics, Inc.
Start My Free Trial